Bodenrader Mark

CIK 00018303711 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001830371

Recent Transactions

18 trades

Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−17,724→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-08-01−24,852→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-08-01−277,817→ 0 total
Award
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-01-19+24,852→ 24,852 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-20$41.42/sh−7,889→ 17,724 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-19+5,085→ 25,613 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-12-19−5,085→ 0 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-19+14,199→ 20,528 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-12-19−14,199→ 0 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-06-02$32.95/sh−1,895→ 5,522 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-06-01+4,733→ 7,417 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-06-01−4,733→ 14,199 total
Award
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-02-06+5,085→ 5,085 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-02-06+20,012→ 20,012 total
Award
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2022-06-01+18,932→ 18,932 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-02-09+24,800→ 24,800 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2021-02-03+90,000→ 90,000 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2020-10-28+65,445→ 65,445 total

Companies

Cerevel Therapeutics Holdings, Inc.
See Remarks

Recent Filings

Address

C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 131 DARTMOUTH STREET, SUITE 502

BOSTON, MA, 02116

View on SEC.gov